Detalles de la búsqueda
1.
A phase III, randomized, two-armed, double-blind, parallel, active controlled, and non-inferiority clinical trial to compare efficacy and safety of biosimilar adalimumab (CinnoRA®) to the reference product (Humira®) in patients with active rheumatoid arthritis.
Arthritis Res Ther
; 19(1): 168, 2017 07 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-28728599
Resultados
1 -
1
de 1
1
Próxima >
>>